跳至主要内容
临床试验/NCT03677011
NCT03677011已完成不适用

Andrositol® TEST as Diagnostic Assay to Predict the Fertilization Potential of the Sperm in the in Vitro Fertilization (IVF) Procedures.

Lo.Li.Pharma s.r.l2 个研究点 分布在 1 个国家目标入组 249 人开始时间: 2018年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
249
试验地点
2
主要终点
increment of the fertilization rate

研究概览

简要总结

Andrositol® test allows to obtain additional information besides the WHO parameters and to evaluate the semen energetic status. The diagnosis is performed by analyzing the semen at two different time points: before the treatment and 30' after the addiction of myo-inositol directly to the semen. The purpose of this study is to evaluate if the responsiveness to the Andrositol® test of a sperm sample can be predictive of its fertilization rate in an ICSI (Intracytoplasmic Sperm Injection) cycle (primary outcome). Secondary outcomes as embryo development, embryo euploidy status and embryo implantation rate will be evaluated.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • male partners of couples undergoing an egg donor cycles

排除标准

  • sperm volume lower than 1 ml
  • sperm count lower than 5 X 106 /ml
  • total sperm motility lower than 10%

结局指标

主要结局

increment of the fertilization rate

时间窗: up to 20 hours after ICSI

measurement of the % oocytes become fertilized by sperm cells. This outcome, is calculated for each patient at day + 1 (14-20h after icsi)

次要结局

  • Increment of implantation rate(up to 10 days after ICSI)
  • embryo development(up to 6 days after ICSI)
  • embryo euploidy(from 10 days after ICSI)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Andrositol® TEST as Diagnostic Assay to Predict the... | 临床试验